Achin Gupta To Succeed Umang Vohra As Cipla’s Global CEO & MD

Achin Gupta, Global Chief Operating Officer (COO), has been elevated as the Global Chief Executive Officer and Managing Director (CEO & MD) of Cipla Limited with effect from April 1, 2026, subject to the approval of the shareholders.

Further, Meera Vanjari, General Counsel (Designate), has transitioned to Global General Counsel and Senior Management Personnel (SMP) of the company with effect from April 1, 2026. She will succeed A.S. Kumar, who will complete his term on March 31, 2026.

Meanwhile, Umang Vohra, Global CEO & MD, expressed his intention not to seek reappointment and consequently retire upon completion of his current term, effective March 31, 2026.

At Cipla, Gupta is currently overseeing commercial markets, API, manufacturing, and supply chain operations. He joined Cipla in 2021 as the CEO of the One India business and has been an integral part of the Management Council. During his tenure, he drove strong growth, expanded Cipla’s presence in chronic therapies and underserved geographies, and strengthened its operational foundations. He holds an M.Tech in Biochemical Engineering and Biotechnology from IIT Delhi and an MBA from IIM Ahmedabad.

Meera Vanjari brings over three decades of extensive global experience in leading legal, compliance, and intellectual property (IP) functions across reputed organisations such as Glenmark, Johnson & Johnson, Bunge, Kodak, Marico, and Abbott Healthcare. Before joining Cipla, she served as Area Counsel and Member of the Business Advisory Committee at Abbott Healthcare, India, where she oversaw legal operations across the company’s India business. Vanjari has received multiple honours, including the “Outstanding Corporate Counsel – Pharmaceutical Sector Award” and recognition in ‘India’s General Counsel Power List’ by The Legal 500.

a

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: